FundedIQ
Biotechnology

Cartography Biosciences: Funding, Investors & Team (Sep 2026)

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

cartography.bio LinkedIn South San Francisco, United States 11-50 employees
Total raised
$67.0M
Rounds
2
Latest
Undisclosed round
May 2026

Cartography Biosciences has raised $67.0M across 2 funding rounds on record, the most recent an undisclosed round announced in May 2026.

Cartography Biosciences Company Profile and Key Stats

Total funding raised
$67.0M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
May 2026
Employees
11-50
reported band
Headquarters
South San Francisco, United States

Latest funding round on record: May 2026.

Cartography Biosciences Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Series B
$67.0M

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Cartography Biosciences raised $67.0M in a Series B announced in Oct 2025.

7 months later, an undisclosed round was announced in May 2026 with no disclosed amount.

Cartography Biosciences Founders and Leadership Team

Name
Role
Contact
Kevin Parker
Founder
Locked
Kevin Parker, Ph.D.
CEO
Locked

Contact details for the Cartography Biosciences team: 2 of 2 have an email address on file.

Start 14-day free trial →

Cartography Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
29,722
$7.5M

Funded Startups Like Cartography Biosciences in Biotechnology and South San Francisco

Companies Similar to Cartography Biosciences

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading…

Undisclosed round $5.3M

Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures…

Seed $8.0M

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

Series A $65.0M

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and…

Series A $80.0M

Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe…

Series A $70.0M

Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for…

Undisclosed round $14.5M

Ventuno Biotech is a biotech company that is developing innovative cancer therapies.

Seed $2.3M

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

Series A $32.0M

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the…

Series A $185M

Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies

Pre-Seed $3.5M

Treating the seeds of cancer

Seed $4.7M

Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.

Seed $6.7M

Cartography Biosciences Funding FAQs

What does Cartography Biosciences do?

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

How much funding has Cartography Biosciences raised?

Cartography Biosciences has raised $67.0M across 2 rounds on record.

When did Cartography Biosciences last raise funding?

Cartography Biosciences' most recent funding round on record was announced in May 2026. The amount was not disclosed.

Who founded Cartography Biosciences?

FundedIQ lists Kevin Parker (Founder) at Cartography Biosciences.

Who is the CEO of Cartography Biosciences?

Kevin Parker, Ph.D. is listed as CEO at Cartography Biosciences.

Where is Cartography Biosciences headquartered?

Cartography Biosciences is based in South San Francisco, United States.

How many employees does Cartography Biosciences have?

Cartography Biosciences is in the 11-50 employee band.

About FundedIQ's Cartography Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cartography Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.